Depression and stress: Is there an endophenotype?

Revista Brasileira de Psiquiatria

Volumn 29, Issue SUPPL. 1, 2007, Pages

  Mello, Andrea Feijo ^a,d   Juruena, Mario Francisco ^b   Pariante, Carmine M ^b   Tyrka, Audrey R ^c   Price, Lawrence H ^c   Carpenter, Linda L ^c   Del Porto, Jose Alberto ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c BROWN UNIVERSITY   (United States)

^d NONE   (Brazil)

Author keywords

Corticotropin releasing hormone; Depression; Hypothalamus hypophyseal system; Pituitary adrenal system; Stress

Indexed keywords

DEXAMETHASONE; SEROTONIN TRANSPORTER; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DIAGNOSTIC AGENT; GLUCOCORTICOID;

CHILD ABUSE; CHILD NEGLECT; CHILDHOOD; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; DISEASE SEVERITY; DNA POLYMORPHISM; ENDOCRINE DISEASE; ENDOCRINE FUNCTION; EXPERIENCE; GENE; GENOTYPE; HUMAN; HYPERCORTISOLISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHESIS; LITERATURE; MELANCHOLIA; PARENTAL DEPRIVATION; PHENOTYPE; PROMOTER REGION; PSYCHOSIS; REVIEW; STRESS; TEMPERAMENT; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MAJOR DEPRESSION; MENTAL STRESS; METABOLISM; PATHOPHYSIOLOGY;

ADRENOCORTICOTROPIC HORMONE; CORTICOTROPIN-RELEASING HORMONE; DEPRESSIVE DISORDER, MAJOR; DEXAMETHASONE; GENETIC PREDISPOSITION TO DISEASE; GLUCOCORTICOIDS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PHENOTYPE; PITUITARY-ADRENAL SYSTEM; POLYMORPHISM, GENETIC; STRESS, PSYCHOLOGICAL; TEMPERAMENT;

EID: 34249795782     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Holsboer F, Barden N. Antidepressants and hypothalamic-pituitary- adrenocortical regulation. Endocr Rev. 1996;17(2):187-205.
2. Carroll BJ, Curtis GC, Mendels J. Neuroendocrine regulation in depression. II. Discrimination of depressed from nondepressed patients. Arch Gen Psychiatry. 1976;33(9):1051-8.
3. Ribeiro SC, Tandon R, Grunhaus L, Greden JF. The DST as a predictor of outcome in depression: a meta-analysis. Am J Psychiatry. 1993;150(11):1618-29.
4. von Bardeleben U, Holsboer F. Effect of age on the cortisol response to human corticotropin-releasing hormone in depressed patients pretreated with dexamethasone. Biol Psychiatry. 1991;29(10):1042-50.
5. von Bardeleben U, Holsboer F, Stalla GK, Muller OA. Combined administration of human corticotropin-releasing factor and lysine vasopressin induces cortisol escape from dexamethasone suppression in healthy subjects. Life Sci. 1985;37(17):1613-8.
6. Watson S, Gallagher P, Smith MS, Ferrier IN, Young AH. The dex/CRH test - is it better than the DST? Psychoneuroendocrinology. 2006;31(7):889-94.
7. Zobel AW, Nickel T, Sonntag A, Uhr M, Holsboer F, Ising M. Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study. J Psychiatr Res. 2001;35(2):83-94.
8. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology. 2000;23(5):477-501.
9. Pariante CM, Papadopoulos AS, Poon L, Checkley SA, English J, Kerwin RW, Lightman S. A novel prednisolone suppression test for the hypothalamic- pituitary-adrenal axis. Biol Psychiatry. 2002;51(11):922-30.
10. Juruena MF, Cleare AJ, Papadopoulos AS, Poon L, Lightman S, Pariante CM. Different responses to dexamethasone and prednisolone in the same depressed patients. Psychopharmacology (Berl). 2006;189(2):225-35.
11. Juruena MF, Cleare AJ, Pariante CM. [The hypothalamic pituitary adrenal axis, glucocorticoid receptor function and relevance to depression]. Rev Bras Psiquiatr. 2004;26(3):189-201.
12. Hasler G, Drevets WC, Manji HK, Charney DS. Discovering endophenotypes for major depression. Neuropsychopharmacology. 2004;29(10):1765-81.
13. Juruena MF. Overlap between atypical depression, seasonal affective disorder and chronic fatigue syndrome. Rev Bras Psiquiatr. 2007;29(Supl I):S119-26.
14. Schmider J, Lammers CH, Gotthardt U, Dettling M, Holsboer F, Heuser IJ. Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I. Biol Psychiatry. 1995;38(12):797-802.
15. Watson S, Gallagher P, Ritchie JC, Ferrier IN, Young AH. Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder. Br J Psychiatry. 2004;184:496-502.
16. Young EA, Abelson JL, Cameron OG. Effect of comorbid anxiety disorders on the hypothalamic-pituitary-adrenal axis response to a social stressor in major depression. Biol Psychiatry. 2004;56(2):113-20.
17. Belanoff JK, Flores BH, Kalezhan M, Sund B, Schatzberg AF. Rapid reversal of psychotic depression using mifepristone. J Clin Psychopharmacol. 2001;21(5):516-21.
18. Coryell W. Psychotic depression. J Clin Psychiatry. 1996;57(Suppl 3):27-31.
19. Schatzberg AF, Rothschild AJ, Stahl JB, Bond TC, Rosenbaum AH, Lofgren SB, MacLaughlin RA, Sullivan MA, Cole JO. The dexamethasone suppression test: identification of subtypes of depression. Am J Psychiatry. 1983;140(1):88-91.
20. Gomez RG, Fleming SH, Keller J, Flores B, Kenna H, DeBattista C, Solvason B, Schatzberg AF. The neuropsychological profile of psychotic major depression and its relation to cortisol. Biol Psychiatry. 2006;60(5):472-8.
21. Contreras F, Menchon JM, Urretavizcaya M, Navarro MA, Vallejo J, Parker G. Hormonal differences between psychotic and non-psychotic melancholic depression. J Affect Disord. 2006; [Epub ahead of print].
22. Keller J, Flores B, Gomez RG, Solvason HB, Kenna H, Williams GH, Schatzberg AF. Cortisol circadian rhythm alterations in psychotic major depression. Biol Psychiatry. 2006;60(3):275-81.
23. Taylor SE, Way BM, Welch WT, Hilmert CJ, Lehman BJ, Eisenberger NI. Early family environment, current adversity, the serotonin transporter promoter polymorphism, and depressive symptomatology. Biol Psychiatry. 2006;60(7):671-6.
24. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwhite A, Boulton R. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003;301(5631):386-9.
25. Eley TC, Sugden K, Corsico A, Gregory AM, Sham P, McGuffin P, Plomin R, Craig IW. Gene-environment interaction analysis of serotonin system markers with adolescent depression. Mol Psychiatry. 2004;9(10):908-15.
26. Grabe HJ, Lange M, Wolff B, Volzke H, Lucht M, Freyberger HJ, John U, Cascorbi I. Mental and physical distress is modulated by a polymorphism in the 5-HT transporter gene interacting with social stressors and chronic disease burden. Mol Psychiatry. 2005;10(2):220-4.
27. Kaufman J, Yang BZ, Douglas-Palumberi H, Houshyar S, Lipschitz D, Krystal JH, Gelernter J. Social supports and serotonin transporter gene moderate depression in maltreated children. Proc Natl Acad Sci U S A. 2004;101(49):17316-21.
28. Kendler KS, Kuhn JW, Vittum J, Prescott CA, Riley B. The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Arch Gen Psychiatry. 2005;62(5):529-35.
29. Wilhelm K, Mitchell PB, Niven H, Finch A, Wedgwood L, Scimone A, Blair IP, Parker G, Schofield PR. Life events, first depression onset and the serotonin transporter gene. Br J Psychiatry. 2006;188:210-5.
30. Zalsman G, Huang YY, Oquendo MA, Burke AK, Hu XZ, Brent DA, Ellis SP, Goldman D, Mann JJ. Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression. Am J Psychiatry. 2006;163(9):1588-93.
31. Surtees PG, Wainwright NW, Willis-Owen SA, Luben R, Day NE, Flint J. Social adversity, the serotonin transporter (5-HTTLPR) polymorphism and major depressive disorder. Biol Psychiatry. 2006;59(3):224-9.
32. Gillespie NA, Whitfield JB, Williams B, Heath AC, Martin NG. The relationship between stressful life events, the serotonin transporter (5-HTTLPR) genotype and major depression. Psychol Med. 2005;35(1):101-11.
33. Mello AA, Mello MF, Carpenter LL, Price LH. Update on stress and depression: the role of the hypothalamic-pituitary-adrenal (HPA) axis. Rev Bras Psiquiatr. 2003;25(4):231-8.
34. Bifulco A, Moran PM, Baines R, Bunn A, Stanford K. Exploring psychological abuse in childhood: II. Association with other abuse and adult clinical depression. Bull Menninger Clinic. 2002;66(3):241-58.
35. Brown GR, Anderson B. Psychiatric morbidity in adult inpatients with childhood histories of sexual and physical abuse. Am J Psychiatry. 1991;148(1):55-61.
36. Fergusson DM, Swain-Campbell NR, Horwood LJ. Does sexual violence contribute to elevated rates of anxiety and depression in females? Psychol Med. 2002;32(6):991-6.
37. Shea A, Walsh C, Macmillan H, Steiner M. Child maltreatment and HPA axis dysregulation: relationship to major depressive disorder and post traumatic stress disorder in females. Psychoneuroendocrinology. 2005;30(2):162-78.
38. Burke HM, Davis MC, Otte C, Mohr DC. Depression and cortisol responses to psychological stress: a meta-analysis. Psychoneuroendocrinology. 2005;30(9):846-56.
39. Yehuda R. Neuroendocrine aspects of PTSD. Handb Exp Pharmacol. 2005(169):371-403.
40. Kendler KS, Kuhn J, Prescott CA. The interrelationship of neuroticism, sex, and stressful life events in the prediction of episodes of major depression. Am J Psychiatry. 2004;161(4):631-6.
41. Hansen-Grant S. Neuroendocrine and immune system pathology in psychiatric disease. In: Schatzberg AF, Nemeroff CB, editors. Textbook of psychopharmacology. 2nd edition. Washington, DC: American Psychiatric Press, Inc; 1998. p. 171-5.
42. Heim C, Newport DJ, Heit S, Graham YP, Wilcox M, Bonsall R, Miller AH, Nemeroff CB. Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA. 2000;284(5):592-7.
43. Moskvina V, Farmer A, Swainson V, O'Leary J, Gunasinghe C, Owen M, Preisig M, Reich T, Rietschel M, Farmer A, McGuffin D. Interrelationship of childhood trauma, neuroticism, and depressive phenotype. Depress Anxiety. 2006; [Epub ahead of print].
44. Nemeroff CB, Heim CM, Thase ME, Klein DN, Rush AJ, Schatzberg AF, Ninan PT, McCullough JP Jr, Weiss PM, Dunner DL, Rothbaum BO, Kornstein S, Keitner G, Keller MB. Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. Proc Natl Acad Sci U S A. 2003;100(24):14293-6. Erratum in: Proc Natl Acad Sci U S A. 2003;102(45):16530.
45. Angst J, Clayton P. Premorbid personality of depressive, bipolar, and schizophrenic patients with special reference to suicidal issues. Compr Psychiatry. 1986;27(6):511-32.
46. Hirschfeld RM, Klerman GL, Lavori P, Keller MB, Griffith P, Coryell W. Premorbid personality assessments of first onset of major depression. Arch Gen Psychiatry. 1989;46(4):345-50.
47. Nash MW, Huezo-Diaz P, Williamson RJ, Sterne A, Purcell S, Hoda F, Cherny SS, Abecasis GR, Prince M, Gray JA, Ball D, Asherson P, Mann A, Goldberg D, McGuffin P, Farmer A, Plomin R, Craig IW, Sham PC. Genome-wide linkage analysis of a composite index of neuroticism and mood-related scales in extreme selected sibships. Hum Mol Genet. 2004;13(19):2173-82.
48. Sen S, Burmeister M, Ghosh D. Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits. Am J Med Genet B Neuropsychiatr Genet. 2004;127(1):85-9.
49. Fox NA, Henderson HA, Marshall PJ, Nichols KE, Ghera MM. Behavioral inhibition: linking biology and behavior within a developmental framework. Annu Rev Psychol. 2005;56:235-62.
50. Kalin NH, Shelton SE. Nonhuman primate models to study anxiety, emotion regulation, and psychopathology. Ann N Y Acad Sci. 2003;1008:189-200.
51. Rosenbaum JF, Biederman J, Gersten M, Hirshfeld DR, Meminger SR, Herman JB, Kagan J, Reznick JS, Snidman N. Behavioral inhibition in children of parents with panic disorder and agoraphobia. A controlled study. Arch Gen Psychiatry. 1988;45(5):463-70.
52. Hirshfeld DR, Rosenbaum JF, Biederman J, Bolduc EA, Faraone SV, Snidman N, Reznick JS, Kagan J. Stable behavioral inhibition and its association with anxiety disorder. J Am Acad Child Adolesc Psychiatry. 1992;31(1):103-11.
53. Prior M, Smart D, Sanson A, Oberklaid F. Does shy-inhibited temperament in childhood lead to anxiety problems in adolescence? J Am Acad Child Adolesc Psychiatry. 2000;39(4):461-8.
54. Heim C, Nemeroff CB. The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol Psychiatry. 2001;49(12):1023-39.
55. McFarlane A, Clark CR, Bryant RA, Williams LM, Niaura R, Paul RH, Hitsman BL, Stroud L, Alexander DM, Gordon E. The impact of early life stress on psychophysiological, personality and behavioral measures in 740 non-clinical subjects. J Int Neurosci. 2005;4(1):27-40.
56. Rijsdijk FV, Sham PC, Sterne A, Purcell S, McGuffin P, Farmer A, Goldberg D, Mann A, Cherny SS, Webster M, Ball D, Eley TC, Plomin R. Life events and depression in a community sample of siblings. Psychol Med. 2001;31(3):401-10.
57. Kagan J, Reznick JS, Snidman N. The physiology and psychology of behavioral inhibition in children. Child Dev. 1987;58(6):1459-73.
58. Tyrka AR, Mello AF, Mello MF, Gagne GG, Grover KE, Anderson GM, et al. Temperament and hypothalamic-pituitary-adrenal axis function in healthy adults. Psychoneuroendocrinology. 2006;31(9):1036-45.
59. Kendler KS, Hettema JM, Butera F, Gardner CO, Prescott CA. Life event dimensions of loss, humiliation, entrapment, and danger in the prediction of onsets of major depression and generalized anxiety. Arch Gen Psychiatry. 2003;60(8):789-96.
60. Holsboer F. Neuroendocrinology of mood disorders. In: Bloom FE, Kupfer ED, editors. Psychopharmacology: the fourth generation of progress. New York: Raven Press; 1995. Chapter 83; p. 957-99.
61. Modell S, Lauer CJ, Schreiber W, Huber J, Krieg JC, Holsboer F. Hormonal response pattern in the combined DEX-CRH test is stable over time in subjects at high familial risk for affective disorders. Neuropsychopharmacology. 1998;18(4):253-62.